Novo Holdings, the primary shareholder of Novo Nordisk A/S and Novozymes A/S, manages a substantial investment portfolio with a focus on long-term returns. As the asset management arm of the Novo Nordisk Foundation—one of the world’s largest philanthropic enterprise foundations—Novo Holdings plays a central role in stewarding the Foundation's wealth. In addition to handling a broad mix of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a global leader in life sciences investment. Through its Seeds, Venture, Growth, and Principal Investments teams, the company supports life science companies at every stage of development